Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3379)
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,635
Price
$80.16
Total Value
$451.70K
Shares Held After
4,669
% of Holdings
54.7%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
26,000
Price
$81.05
Total Value
$2.11M
Shares Held After
77,114
% of Holdings
25.2%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
851
Price
$75.00
Total Value
$63.83K
Shares Held After
52,173
% of Holdings
1.6%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
7,718
Price
$85.26
Total Value
$658.04K
Shares Held After
60,137
% of Holdings
11.4%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
412
Price
$85.23
Total Value
$35.11K
Shares Held After
60,137
% of Holdings
0.7%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
1,434
Price
$46.86
Total Value
$67.20K
Shares Held After
168,235
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,729
Price
$118.66
Total Value
$205.16K
Shares Held After
472,267
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,069
Price
$117.85
Total Value
$361.68K
Shares Held After
473,996
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,701
Price
$117.09
Total Value
$199.17K
Shares Held After
477,065
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
952
Price
$115.69
Total Value
$110.14K
Shares Held After
478,766
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,896
Price
$114.94
Total Value
$447.81K
Shares Held After
479,718
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,083
Price
$113.97
Total Value
$237.40K
Shares Held After
483,614
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
78
Price
$112.49
Total Value
$8.77K
Shares Held After
485,697
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,442
Price
$111.51
Total Value
$160.80K
Shares Held After
485,775
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,579
Price
$110.49
Total Value
$174.46K
Shares Held After
487,217
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,562
Price
$109.79
Total Value
$500.86K
Shares Held After
488,796
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,402
Price
$108.14
Total Value
$3.50M
Shares Held After
493,358
% of Holdings
6.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,958
Price
$107.57
Total Value
$425.76K
Shares Held After
525,760
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,390
Price
$118.66
Total Value
$1.47M
Shares Held After
2,451,924
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
22,046
Price
$117.85
Total Value
$2.60M
Shares Held After
2,464,314
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12,181
Price
$117.09
Total Value
$1.43M
Shares Held After
2,486,360
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
6,821
Price
$115.69
Total Value
$789.12K
Shares Held After
2,498,541
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
27,951
Price
$114.94
Total Value
$3.21M
Shares Held After
2,505,362
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,913
Price
$113.97
Total Value
$1.70M
Shares Held After
2,533,313
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
555
Price
$112.49
Total Value
$62.43K
Shares Held After
2,548,226
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,366
Price
$111.51
Total Value
$1.16M
Shares Held After
2,548,781
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,277
Price
$110.49
Total Value
$1.25M
Shares Held After
2,559,147
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
32,624
Price
$109.79
Total Value
$3.58M
Shares Held After
2,570,424
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
231,007
Price
$108.14
Total Value
$24.98M
Shares Held After
2,603,048
% of Holdings
8.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
28,296
Price
$107.57
Total Value
$3.04M
Shares Held After
2,834,055
% of Holdings
1.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
596
Price
$482.50
Total Value
$287.57K
Shares Held After
15,337
% of Holdings
3.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$44.90
Total Value
$112.25K
Shares Held After
886
% of Holdings
73.8%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
232
Price
$44.90
Total Value
$10.42K
Shares Held After
886
% of Holdings
20.8%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$45.64
Total Value
$684.60K
Shares Held After
1,647
% of Holdings
90.1%
Vericel Corp (VCEL)
Mara Joseph Anthony Jr — Chief Financial Officer
Shares
5,000
Price
$44.75
Total Value
$223.75K
Shares Held After
16,009
% of Holdings
23.8%
Fulcrum Therapeutics, Inc. (FULC)
Ezekowitz Alan — Director
Shares
18,000
Price
$3.65
Total Value
$65.61K
Shares Held After
10,927
% of Holdings
62.2%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.54
Total Value
$231.00K
Shares Held After
150,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
134
Price
$2.54
Total Value
$340.36
Shares Held After
2,469,083
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
75,047
Price
$2.55
Total Value
$191.37K
Shares Held After
2,468,949
% of Holdings
3.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
500,000
Price
$34.08
Total Value
$17.04M
Shares Held After
18,677,617
% of Holdings
2.6%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,700
Price
$34.00
Total Value
$499.85K
Shares Held After
65,631
% of Holdings
18.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
11,421
Price
$26.08
Total Value
$297.91K
Shares Held After
13,088
% of Holdings
46.6%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
4,103
Price
$17.46
Total Value
$71.64K
Shares Held After
30,346
% of Holdings
11.9%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
24,543
Price
$17.46
Total Value
$428.55K
Shares Held After
1,192,840
% of Holdings
2.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
1,876
Price
$8.98
Total Value
$16.85K
Shares Held After
16,795,919
% of Holdings
0.0%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
2,264
Price
$17.46
Total Value
$39.53K
Shares Held After
35,691
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$553.49
Total Value
$22.14K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$552.36
Total Value
$154.66K
Shares Held After
40,553
% of Holdings
0.7%
Showing 1101–1150 of 3379 transactions (page 23 of 68)